MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals _ Orphan & Rare Diseases
Denali Therapeutics Inc. (NASDAQ: DNLI)*
Organization & Developments: Denali Therapeutics
Parents
Denali Therapeutics Inc. (NASDAQ: DNLI)*
Children
*Denali was founded by Ryan Watts, who was the head of the neuroscience department at Genentech
*It has a mechanism that allows drugs to sneak past the blood-brain barrier, O
2019: Big Pharma Has Mad Love For These 2 Biotechs_Regenxbio, Denali
2021: Denali Is Getting To Be More And More Interesting
2021: Denali: A $10B Early Stage Biotech Targeting Parkinson's Disease
2022: Denali Therapeutics: 2021 Was Mostly Bad Luck And Trouble
2022: Denali Therapeutics: Two Shots On Goal For Parkinson's Disease Treatment_ seekingalpha.com
2023: Diving Into Denali Therapeutics_ seekingalpha.com
2024: Denali Has A Neurodegenerative Edge Despite Market Skepticism
2024: Denali Therapeutics Continues To Have Plenty Of Moving Parts_seekingalpha
2024: Denali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing Technology
2024: Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
2024: Sanofi, Denali Abandon Mid-Stage Multiple Sclerosis Study on Disappointing Data
2025: Denali Therapeutics: Vast Pipeline, First Approval Up Ahead
Jumps
*Key People: Denali Therapeutics
Finance & Acquisitions: Denali Therapeutics